rs387907040
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PP3_ModeratePP5
The NM_024306.5(FA2H):c.460C>T(p.Arg154Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00000929 in 1,614,020 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R154H) has been classified as Uncertain significance.
Frequency
Consequence
NM_024306.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FA2H | NM_024306.5 | c.460C>T | p.Arg154Cys | missense_variant | 3/7 | ENST00000219368.8 | |
FA2H | XM_011523317.4 | c.460C>T | p.Arg154Cys | missense_variant | 3/6 | ||
FA2H | XM_011523319.3 | c.220C>T | p.Arg74Cys | missense_variant | 3/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FA2H | ENST00000219368.8 | c.460C>T | p.Arg154Cys | missense_variant | 3/7 | 1 | NM_024306.5 | P1 | |
FA2H | ENST00000569949.1 | c.262C>T | p.Arg88Cys | missense_variant | 3/5 | 4 | |||
FA2H | ENST00000567683.5 | c.364-8130C>T | intron_variant, NMD_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152172Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251280Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135842
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461848Hom.: 0 Cov.: 32 AF XY: 0.00000550 AC XY: 4AN XY: 727222
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152172Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74342
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 35 Pathogenic:3
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 2010 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | May 03, 2020 | - - |
Likely pathogenic, no assertion criteria provided | clinical testing | Genomics England Pilot Project, Genomics England | - | - - |
Spastic paraplegia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 27, 2022 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 154 of the FA2H protein (p.Arg154Cys). This variant is present in population databases (rs387907040, gnomAD 0.01%). This missense change has been observed in individuals with clinical features of FA2H-related conditions (PMID: 20853438, 27217339, 31135052, 32907636). ClinVar contains an entry for this variant (Variation ID: 30872). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FA2H protein function. Studies have shown that this missense change alters FA2H gene expression (PMID: 20853438). For these reasons, this variant has been classified as Pathogenic. - |
Neurodegeneration with brain iron accumulation Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 16, 2023 | Variant summary: FA2H c.460C>T (p.Arg154Cys) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.4e-05 in 251280 control chromosomes. c.460C>T has been reported in the literature in multiple individuals affected with FA2H-related conditions (e.g., Kruer_2010, Rattay_2019, Tsang_2020). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence demonstrating reduced levels of protein expression in mutant cells, indicating reduced stability of the mRNA or protein product (Kruer_2010). The following publications have been ascertained in the context of this evaluation (PMID: 20853438, 31135052, 32907636). Three ClinVar submitters have submitted clinical-significance assessments for this variant to ClinVar after 2014. One submitter classified the variant as a variant on uncertain significance, while two submitter classified it as likely pathogenic/pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 17, 2022 | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Not observed at a significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 29376581, 34758253, 24299421, 20853438, 29423566, 25141825, 31589614, 32907636, 34852264, 31837835, 27217339, 31135052) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at